Heart rate variability on antihypertensive drugs in black patients living in sub-Saharan Africa

References

• Singh JP, Larson MG, Tsuji H, Evans JC, O’Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: Insights into pathogenesis of hypertension: The Framingham Heart Study. Hypertension. 1998;32:293–297.
   PubMed Web of Science ®Google Scholar
• Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate variability: A measure of cardiac autonomic tone. Am Heart J. 1994;127:1376–1381.
   PubMed Web of Science ®Google Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93: 1043–1065.
   PubMed Web of Science ®Google Scholar
• Malliani A, Pagani M, Lombardi F, Furlan R, Guzzetti S, Cerutti S. Spectral analysis to assess increased sympathetic tone in arterial hypertension. Hypertension. 1991;17 Suppl III: III–36–III–42.
   Web of Science ®Google Scholar
• Liao D, Cai J, Barnes RW, Tyroler HA, Rautahariu P, Holme I et al. Association of cardiac autonomic function and the development of hypertension: The ARIC study. Am J Hypertens. 1996;9:1147–1156.
   PubMed Web of Science ®Google Scholar
• Tsuji H, Venditti FJ, Jr., Manders ES, Evans JC, Larson MG, Feldman CL et al. Reduced heart rate variability and mortality in an elderly cohort. The Framingham Heart Study. Circulation. 1994;90:878–883.
   PubMed Web of Science ®Google Scholar
• Tsuji H, Larson MG, Venditti FJ, Manders ES, Evans JC, Feldman CL et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996;94:2850–2855.
   PubMed Web of Science ®Google Scholar
• Choi JB, Hong S, Nelesen R, Bardwell WA, Natarajan L, Schubert C et al. Age and ethnicity differences in short-term heart-rate variability. Psychosom Med. 2006;68:421–426.
   PubMed Web of Science ®Google Scholar
• Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52:818–827.
   PubMed Web of Science ®Google Scholar
• Esco MR, Olson MS, Williford HN. Racial differences exist in cardiovascular parasympathetic modulation following maximal exercise. J Appl Res. 2010;10:?
   Google Scholar
• Liao D, Barnes RW, Chambless LE, Simpson RJ, Jr., Sorlie P, Heiss G. Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability — the ARIC study. Ahterosclerosis Risk in Communities. Am J Cardiol. 1995;76:906–912.
   PubMed Web of Science ®Google Scholar
• Stein CM, Lang CC, Xie HG, Wood AJ. Hypertension in black people: Study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on race. Pharmacogenetics. 2001;11:95–110.
   PubMedGoogle Scholar
• Wali RK, Weir MR. Hypertensive cardiovascular disease in African Americans. Curr Hypertens Rep. 1999; 1:521–528.
   PubMedGoogle Scholar
• Zion AS, Bond V, Adams RG, Williams D, Fullilove RE, Sloan RP et al. Low arterial compliance in young African-American males. Am J Physiol Heart Circ Physiol. 2003; 285:H457–H462.
   PubMed Web of Science ®Google Scholar
• Kotecha D, New G, Flather MD, Eccleston D, Pepper J, Krum H. Five-minute heart rate variability can predict obstructive angiographic coronary disease. Heart. 2012;98: 395–401.
   PubMed Web of Science ®Google Scholar
• Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86:309–312.
   PubMed Web of Science ®Google Scholar
• Odili AN, Richart T, Thijs L, Kingue S, Boombhi HJ, Lemogoum D et al. Rationale and design of the Newer Versus Older Antihypertensive Agents In African Hypertensive Patients (NOAAH) trial. Blood Press. 2011;20:256–266.
   PubMed Web of Science ®Google Scholar
• M’Buyamba-Kabangu JR, Anisiuba BC, Ndiaye MB, Lemogoum D, Jacobs L, Ijoma CK et al. Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa. J Hum Hypertens. 2013; DOI:10.1038/jhh.2013.56.
   PubMed Web of Science ®Google Scholar
• 41st World Medical Assembly. Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ. 1990;24:606–609.
   Google Scholar
• El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: The Omron M5-I and the Omron 705IT. Blood Press Monit. 2003;8:127–133.
   PubMed Web of Science ®Google Scholar
• Lancaster SG, Sorkin EM. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. Drugs. 1988;36:256–285.
   PubMed Web of Science ®Google Scholar
• Brodde OE. The functional importance of beta 1 and beta 2 adrenoceptors in the human heart. Am J Cardiol. 1988;62: 24C–29C.
   PubMed Web of Science ®Google Scholar
• Stolarz K, Staessen JA, Kuznetsova T, Tikhonoff V, State D, Babeanu S et al. Host and environmental determinants of heart rate and heart rate variability in four European populations. J Hypertens. 2003;21:525–535.
   PubMed Web of Science ®Google Scholar
• Asmar RG, London GM, O’Rourke MF, Safar ME, for the REASON Project coordinators and investigators. Improvement in blood pressure, arterial stiffness and wave refelctions with a very-low-dose perindopril/indapamide combination in hypertensive patient. A comparison with atenolol. Hypertension. 2001;38:922–926.
   PubMed Web of Science ®Google Scholar
• Jin Y, Thijs L, Richart T, Li Y, Dolan E, Wang JG et al. Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. Hypertens Res. 2011;34:489–495.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994;23:83–91.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet. 2005;366:895–906.
   PubMed Web of Science ®Google Scholar